Events

10 - 12 Dec 2025

Conference

Check Official Website

Baner
Recommended

AI Development Japan 2025

Join AI_dev Japan 2025 in Tokyo for a premier open-source AI and ML event, featuring keynotes, sessions, and networking opportunities.

08 - 09 Apr 2025

Conference

Check Official Website

Baner
Explore hybrid and full decentralized clinical trials through data, collaboration, and technology integration at this in-person event in Philadelphia.

10 Apr 2025

Conference

Check Official Website

Baner
The 'Unstoppable Innovation' event will explore the value of no-code technology and how the Creatio platform supports business digital transformation. It will cover key features for successful no-code adoption, demonstrate solution creation, and discuss project management methodologies. The presentation will highlight tools like Creatio Copilot and the Governance App, along with analyst recognition and customer success stories.

14 - 15 Apr 2025

Conference

Check Official Website

Baner
Exclusive forum for senior pharma supply chain professionals to share best practices and knowledge on digitization, AI, IoT, and regulatory requirements in Boston, USA.

15 - 16 Apr 2025

Conference

Check Official Website

Baner
Discover cutting-edge AI tools and techniques along with their applications, featuring leading experts from banking, insurance, academia, and the financial industry.

16 - 18 Apr 2025

Conference

Check Official Website

Baner
The Translational Digital Pathology & AI Summit focuses on advancing digital pathology through innovation and collaboration, providing a platform for networking and discussions. It aims to address the needs of the biopharma community, exploring AI applications and strategies to enhance lab workflows and drug development for various medical indications.

10 - 12 Dec 2025

Conference

Check Official Website

Baner
Recommended

AI Development Japan 2025

Join AI_dev Japan 2025 in Tokyo for a premier open-source AI and ML event, featuring keynotes, sessions, and networking opportunities.